Streetbeat News

Products Services

BABA

Investors with significant capital have shown a bullish stance on Alibaba Group Holdings (NYSE:BABA), as observed through unusual options trades. Benzinga's options scanner detected 10 uncommon trades, with a split sentiment of 50% bullish and 50% bearish. The major market movers are focusing on a price range between $55.0 and $120.0. The current trading volume is 1,926,809, with BABA's price up by 0.69% at $72.5. An analyst from Loop Capital maintains a Buy rating with a target price of $115.

Portfolio Pulse from Benzinga Insights

July 01, 2024 | 2:16 pm

HOOD

Robinhood Markets announced an interruption in service for some users and is working to resolve the issue. The company apologized for the inconvenience and promised updates.

Portfolio Pulse from Benzinga Newsdesk

July 01, 2024 | 2:09 pm

OPRA

Opera GX, a browser designed for gamers, has enhanced its built-in AI, Aria, with new features including image generation, voice output, chat summary options, and source links. These updates are part of Opera's Experimental AI Feature Drops program.

Portfolio Pulse from Benzinga Newsdesk

July 01, 2024 | 2:06 pm

LLY

Radionetics Oncology has entered a strategic agreement with Eli Lilly, receiving a $140 million upfront payment. Eli Lilly gains the exclusive right to acquire Radionetics for $1 billion. The partnership will focus on developing GPCR targeting radiopharmaceuticals for solid tumors using Radionetics' proprietary discovery platform.

Portfolio Pulse from Benzinga Newsdesk

July 01, 2024 | 2:04 pm

BA

SPR

Airbus SE has signed a binding term sheet with Spirit AeroSystems Holdings Inc for a potential acquisition of key production activities, including A350 fuselage sections and A220 components. The deal includes a $559 million compensation payment to Airbus and aims to stabilize supply chains for Airbus’s commercial aircraft programs. The agreement is part of a broader division of the supplier between Airbus and Boeing Co.

Portfolio Pulse from Shivani Kumaresan

July 01, 2024 | 1:49 pm

SPY

TEVA

The FTC has opened an investigation into Teva Pharmaceuticals over its refusal to remove patents for its asthma and COPD inhalers, which is seen as a move to block generic competition and inflate prices. This investigation is part of a broader effort by Democrats to address 'junk patent listings' in the pharmaceutical industry.

Portfolio Pulse from Benzinga Newsdesk

July 01, 2024 | 1:44 pm

NVDA

SK Group, the parent company of Nvidia's chip supplier SK Hynix, plans to invest $56 billion in AI and semiconductor technology by 2026. This investment aims to enhance its supply chains and maintain its lead in the high-bandwidth memory (HBM) market, despite competition from Samsung and Micron.

Portfolio Pulse from Benzinga Neuro

July 01, 2024 | 1:35 pm

SYT

SYLA Solar will absorb SYLA Biotech in a non-monetary merger to strengthen its renewable energy business. The merger aims to help SYLA Technologies achieve its mid-term sales targets by 2026, supported by subsidies from the Ministry of Economy, Trade and Industry.

Portfolio Pulse from Benzinga Newsdesk

July 01, 2024 | 1:33 pm

DTSS

FXI

Datasea has announced three new sales agreements totaling $61.7 million with Chinese subsidiaries. These agreements are expected to support revenue growth for its core AI-based businesses in fiscal year 2025. The deals include two agreements for 5G-AI communications and one for high-tech acoustic products.

Portfolio Pulse from Benzinga Newsdesk

July 01, 2024 | 1:31 pm

LLY

MSFT

Eli Lilly (NYSE:LLY) has reached a new 52-week high, driven by a 97.38% increase over the past year and 55.32% year-to-date. The company's collaboration with OpenAI to develop novel antimicrobials and strong technical indicators suggest continued momentum. However, the RSI indicates potential near-term volatility.

Portfolio Pulse from Surbhi Jain

July 01, 2024 | 1:27 pm